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AbSTRACT
In 2017, the British Association for Cardiovascular 
Prevention and Rehabilitation published its official 
document detailing standards and core components for 
cardiovascular prevention and rehabilitation. Building 
on the success of previous editions of this document 
(published in 2007 and 2012), the 2017 update aims to 
further emphasise to commissioners, clinicians, politicians 
and the public the importance of robust, quality 
indicators of cardiac rehabilitation (CR) service delivery. 
Otherwise, its overall aim remains consistent with the 
previous publications—to provide a precedent on which 
all effective cardiovascular prevention and rehabilitation 
programmes are based and a framework for use in 
assessment of variation in service delivery quality. In this 
2017 edition, the previously described seven standards 
and core components have both been revised to six, 
with a greater focus on measurable clinical outcomes, 
audit and certification. The principles within the updated 
document underpin the six-stage pathway of care for CR, 
and reflect the extensive evidence base now available 
within the field. To help improve current services, close 
collaboration between commissioners and CR providers 
is advocated, with use of the CR costing tool in financial 
planning of programmes. The document specifies how 
quality assurance can be facilitated through local 
audit, and advocates routine upload of individual-level 
data to the annual British Heart Foundation National 
Audit of Cardiac Rehabilitation, and application for 
national certification ensuring attainment of a minimum 
quality standard. Although developed for the UK, these 
standards and core components may be applicable to 
other countries.
InTRoduCTIon
This paper summarises the key points of the third 
most recent edition of the standards and core 
components for cardiovascular prevention and 
rehabilitation which were published by the British 
Association for Cardiovascular Prevention and 
Rehabilitation (BACPR) in 20 17.1 Earlier editions 
of this publication were produced by the BACPR in 
20072 and 2012.3 4 This paper presents the current 
evidence base for cardiac rehabilitation (CR), and 
focuses specifically on those recommendations 
within the 2017 publication which are new, or 
which have been updated from the previous 2012 
edition of the document.3 4 The full 2017 edition1 
can be accessed from www. bacpr. com.
Building on success of the 2007 and 2012 publi-
cations,2–4 the aim of the 2017 update was to 
further emphasise to commissioners, clinicians, 
politicians and the public the importance of robust, 
quality indicators of CR service delivery. Other-
wise, its overall aim remains consistent with the 
previous publications2–4—to provide a precedent 
on which all effective cardiovascular prevention 
and rehabilitation programmes (CPRP) are based 
and a framework for use in assessment of variation 
in service delivery quality. To support implementa-
tion of these standards and core components, the 
BACPR has developed online educational modules, 
also available from www. bacpr. com.
The compelling case for cardiovascular 
prevention and rehabilitation
As will be discussed throughout, CR has a robust 
evidence base reducing mortality and morbidity, 
reducing healthcare costs and enhancing the quality 
and productivity of people’s lives. It provides strong 
rationale for the evolution of current services to 
include an ever-expanding spectrum of patients—
from those with established cardiovascular disease 
(CVD) to those who are asymptomatic but at high 
risk of future adverse cardiovascular events.5 6 
Impacting favourably on cardiovascular mortality, 
acute hospitalisation, cardiorespiratory fitness and 
perceived healthy-related quality of life (QoL), 
CPRPs can facilitate early return to work and aid 
development of self-management skills.7–11
Completing a CPRP after myocardial infarction 
(MI) and/or coronary revascularisation significantly 
reduces emergency hospital admissions (from 30.7% 
to 26.1%; number needed to treat (NNT) 22), high-
lighting CR’s overall cost-efficacy.8 12 Furthermore, 
there is an absolute risk reduction in cardiovas-
cular mortality (from 10.4% to 7.6%), compared 
with those who do not attend (NNT 37).8 Research 
suggests that CR does not affect rates of recurrent 
MI and repeat revascularisation, and its effect on 
all-cause mortality in congenital heart disease (CHD) 
is equivocal.13 However, recent work has shown that 
CPRPs which are able to prescribe cardioprotective 
medications, and which intensively manage six risk 
factors or more, can reduce all-cause mortality and 
recurrent MI.14 Certainly, mortality should not be 
considered the only measure of CR’s effectiveness. 
While optimal medical therapy and percutaneous 
intervention for management of CHD add ‘years to 
life’, the potential for CR to add ‘life to years’ should 
not be underestimated, and there is growing recogni-
tion that promotion of CR should focus on its ability 
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Figure 1 Department of Health commissioning guide six-stage patient pathway of care.34 CR, cardiac rehabilitation.
to provide cost-effective and cost-saving secondary CVD preven-
tion.15 Furthermore, those who have participated in CR after MI 
have shown significantly better adherence to their cardioprotective 
medications.16
Notably, for those with heart failure (HF), CR reduces hospi-
talisation, with a 25% relative risk reduction in overall emergency 
admissions and a 39% reduction (NNT 18) in acute HF-related 
episodes.17 In this group, deterioration and readmission have a 
hugely detrimental impact on QoL, associated morbidity and 
financial impact.
As centre-based and home-based CR do not appear to generate 
different outcomes, or incur substantially different healthcare costs, 
the CR setting can be individually tailored to patients’ preferences. 
In some cases, home-based CR has demonstrated a higher utilisa-
tion rate (uptake, adherence and completion)—therefore, services 
have the opportunity for innovative delivery to enhance patient 
recruitment.18–21 There is continued emphasis on the importance 
of early CR—which is both safe and feasible, and improves patient 
uptake and adherence.21–28 If a CR clinician engages with a patient 
in an acute hospital setting, and begins to undertake personalised 
goal setting at this point, then this may lead to higher uptake.25 29
Patients with other non-infectious diseases, particularly those 
with chronic respiratory conditions and certain forms of cancer, 
may also benefit from CR.30 31 Thus, there is an opportunity to 
further expand the scope and influence of prevention and reha-
bilitation services which may, in turn, release financial resources 
to enable more cost-effective deployment of staff and facilities.32
Given its clinical and cost-effectiveness for CVD management, it 
is imperative that structures are in place to maximise CR uptake, 
adherence and completion. The 2017 British Heart Foundation 
(BHF) National Audit of Cardiac Rehabilitation (NACR) reported 
that overall mean uptake to CR in the UK has reached 51% (of 
all eligible patients), which brings the UK’s uptake into the top 
2% of countries in Europe.33 Although these data represent a 
steady increase in uptake, a modelling study conducted by the 
National Health Service (NHS) Improvement in 2013 advocated 
that increasing uptake of CR to 65% of all eligible individuals in 
England would reduce emergency cardiac admissions by 30%, 
releasing more than £30 million per year into the NHS, which 
could be used within rehabilitation and re-enablement.32
CR pathway of care
These 2017 standards and core components provide detail to 
complement the CR six-stage pathway of care set out by the 
Department of Health Commissioning Guide34 which encom-
passes patient presentation (eg, diagnosis or cardiac event), 
ascertaining eligibility, referral and assessment, through to long-
term management (figure 1). There is recognition that each 
stage of the pathway is essential to ensure programme uptake 
and adherence, attainment of meaningful clinical outcomes 
and long-term behaviour change and improvement in health. 
Although designed for England, the pathway is pertinent to all 
four UK nations, and like the standards and core components, 
its basic principles should apply to other countries with state-
funded health services.
national and local factors for assuring quality
Quality assurance within CR is facilitated through an alliance 
both at local (eg, commissioners, CPRP teams) and national 
levels, together with contribution to the NACR and achievement 
of national certification. In 2016, a joint National Certification 
Programme for Cardiac Rehabilitation (NCP_CR) was launched 
by the BACPR and NACR. CPRPs should ultimately strive to 
attain the NCP_CR, which has been designed to demonstrate that 
programmes are meeting (or working towards) a set of quality 
standards, which are reflective of data submitted to the NACR, 
and adapted from those described within this document.1 35 The 
new approach is for all CPRPs to submit current NACR data sets 
and complete the NACR staff survey, http://www. card iacr ehab 
ilit ation. org. uk/ NCP- CR. htm
bACPR standards and core components
In contrast to the 20123 4 edition of this document, which 
included seven standards and seven core components, this 2017 
revision has six standards and six core components, with greater 
emphasis on quantifiable clinical and health outcomes, audit and 
certification.1
Standards of care
Two of the updated standards of care (Standard One and Stan-
dard Six; table 1) emphasise the importance of the administrative 
aspects of CPRPs, while the other four are centred on patient 
participation in terms of recruitment, assessment and clinical 
outcomes.1 In the 20123 4 edition, there was a standard dedi-
cated to the establishment of a CR business case and budget. 
Although not included in the 2017 version as a standard, there 
is updated guidance on developing costing within business cases 
for CPRPs.1 The wording within the new standards has also 
been revised to clarify the strength of recommendations: ‘shall’ 
is used to convey a requirement with which all programmes are 
expected to comply (grade A/B recommendations based on the 
highest quality evidence available and recognised as best prac-
tice), while ‘should’ expresses a desirable recommendation 
(grade C/D recommendation).1
Previously, the first standard specified that each CPRP should 
deliver the core components to ensure clinically effective care 
and sustainable health outcomes, while the second described the 
skill set of the multidisciplinary team required to achieve this.2–4 
As these standards complement each other, they have been 
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Table 1 The six standards for cardiovascular prevention and 
rehabilitation1
The standards
Standard 
One
The delivery of six core components by a qualified and competent 
multidisciplinary team, led by a clinical coordinator.
Standard 
Two
Prompt identification, referral and recruitment of eligible patient 
populations.
Standard 
Three
Early initial assessment of individual patient needs which informs the 
agreed personalised goals that are reviewed regularly.
Standard 
Four
Early provision of a structured cardiovascular prevention and 
rehabilitation programme (CPRP), with a defined pathway of care, 
which meets the individual’s goals and is aligned with patient 
preference and choice.
Standard 
Five
On programme completion, a final assessment of individual patient 
needs and demonstration of sustainable health outcomes.
Standard Six Registration and submission of data to the National Audit for Cardiac 
Rehabilitation (NACR) and participation in the National Certification 
Programme for Cardiac Rehabilitation (NCP_CR).
Table 2 The six standards for cardiovascular prevention and 
rehabilitation1
Standard Two—Patient identification
Priority patient groups that shall be offered a cardiovascular prevention 
and rehabilitation programme (CPRP):
 ► Acute coronary syndrome.
 ► Coronary revascularisation.
 ► Heart failure.
Other patients known to benefit:
 ► Stable angina.
 ► Peripheral arterial disease.
 ► Post-cerebrovascular event.
 ► Post-implantation of cardiac defibrillators and resynchronisation 
devices.
 ► Post-heart valve repair/replacement.
 ► Post-heart transplantation and ventricular assist devices.
 ► Adult congenital heart disease.
Table 3 The six core components for cardiovascular disease 
prevention and rehabilitation1
The six core components
Health behaviour change and 
education
Health behaviour change
Education 
Lifestyle risk factor management Physical activity and exercise
Healthy eating and body composition
Tobacco cessation and relapse prevention 
Psychosocial health
Medical risk management
Long-term strategies Patient responsibilities
Service responsibilities 
Audit and evaluation
amalgamated in the 2017 version.1 The revised Standard One 
also specifies that there shall be inclusion of dedicated admin-
istrative support and involvement of a physician with sufficient 
knowledge of, interest in and dedication to cardiovascular reha-
bilitation and prevention.1
While the 20123 4 edition listed patient groups with CVD who 
should be offered CR, Standard Two within the 2017 version 
explicitly outlines priority groups that shall be offered CR in 
the first instance (eg, dependent on local policy/resources), and 
groups to which programmes ‘should aim to offer’ CR due to 
the known benefit1 (Table 2). There is emphasis that appropri-
ately resourced CPRPs should demonstrate ambition to broaden 
access to provide high-quality and cost-effective input to those 
with established CVD and those with high CVD risk.1 Acknowl-
edging the importance of early intervention, there are specified 
time frames for referral/recruitment, and the standard states that 
CPRPs shall receive the referral of an eligible either during the 
hospital stay or within 24 hours of discharge, or within 72 hours 
of an outpatient being identified as eligible.1
While it was previously recommended that the initial CR 
assessment is undertaken and programme commenced ‘ideally 
within two weeks’,2–4 the updated Standard Three and Stan-
dard Four specify that these shall take place within 10 working 
days of referral, and if the assessment cannot be fully completed, 
this shall not prevent assessment of the remaining aspects or 
initiation of a formal CPRP.1 Furthermore, where commence-
ment of group-based exercise has to be postponed, this shall not 
delay initiating care in relation to other relevant core compo-
nents.1 In this respect, offering alternatives such as home-based 
CR with an evidence base allows flexibility and patient choice.8
The updated Standard Four also states that patients shall 
have access to the multidisciplinary team as required and shall 
be supported to undertake an individualised, structured exer-
cise programme at least two to three times weekly, specifically 
designed to increase physical fitness.1 There is recognition that 
this requires documented evidence of regular review, goal setting 
and training progression, and there shall be documented commu-
nication between the patient and the team for at least 8 weeks.1
While the 20123 4 edition did not include a standard dedicated 
to reassessment, in this 2017 document,1Standard Five ensures 
that patients have achieved sustainable outcomes on completion 
of the CPRP. The standard states that a final assessment shall be 
undertaken which revisits lifestyle risk-related factors, psychoso-
cial health and medical risk management to identify the patient’s 
health outcomes, unmet goals and new or evolving clinical issues 
and to formulating long-term strategies.1 Data from the final 
assessment should be formally documented for audit and eval-
uation and shared with the patient and his/her patient’s primary 
care provider (and the referral source, where relevant) within 10 
days of programme completion.1
In addition to re-emphasising the importance of national audit 
and evaluation by stating that CPRPs shall register and routinely 
submit individual-level baseline and reassessment data on clinical 
outcomes, and patient experience and satisfaction to the NACR, 
Standard Six includes a recommendation that every CPRP should 
strive to meet and maintain requirements for the NCP_CR.1
Core components
The BACPR’s core components for CR represent the ‘coor-
dinated sum of activities required to influence favourably the 
underlying cause of cardiovascular disease, as well as to provide 
the best possible physical, mental and social conditions, so that 
the patients may, by their own efforts, preserve or resume optimal 
functioning in their community and through improved health 
behaviour, slow or reverse progression of disease’.1 This 2017 
publication1 includes six core components (table 3) rather than 
the seven of the 20123 4 edition, with ‘medical risk management’ 
a new single core component that reflects the difficulty of disen-
tangling the interplay between cardioprotective therapies and 
medical risk factors, given that drugs used to modify risk factors 
are also cardioprotective. Aside from this amalgamation, there 
are only minor updates, reflective of updates to the evidence 
base since the last edition was published.
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Figure 2 Cardiac rehabilitation patient pathway aligned with National Audit of Cardiac Rehabilitation (NACR) data entry pathway.1 35 CR, cardiac 
rehabilitation; GP, general practitioner.
Adoption of healthy behaviours and development of self-man-
agement skills remains the foundation of long-term cardiovas-
cular prevention and rehabilitation, and health behaviour change 
and education remains fundamental to all other components of 
CPRP.1 In this updated document, there is recognition that the 
educational component should take account of different learning 
styles, should be tailored to individual learning needs and should 
use best available resources (in different formats, using plain 
language and clear design) to enable patients to learn about their 
condition and management.1
In addition to increasing physical fitness and overall daily 
energy expenditure, the updated lifestyle risk factor management 
component states that an additional aim of physical activity and 
exercise training is to decrease sedentary behaviour.1 There is a 
focus on healthy eating and body composition as opposed to ‘diet’, 
and a new recommendation that patients with more complex 
dietary needs should be under care of a registered dietitian.1 
There is also inclusion of bariatric surgery as a potential specialist 
intervention strategy to comanage weight loss.1 Acknowledging 
that the harmful effects of tobacco extend beyond cigarette 
smoking, there is focus on tobacco (rather than smoking) cessa-
tion, and greater emphasis on assessing and addressing tobacco 
use by others within the home.1 The component states that 
patient choice is a priority when selecting a tobacco cessation 
method, and recognises that, with a growing evidence base for 
their efficacy, e-cigarettes should be considered.1
In assessment of psychosocial health, this 2017 document1 
provides specific examples of tools for measuring psychological 
distress (eg, anxiety and depression, using the Hospital Anxiety and 
Depression Scale) and QoL (eg, using the Dartmouth Primary Care 
Cooperative or Minnesota Living with Heart Failure Question-
naire) and specifies that, in addition, patients should be assessed 
for psychological stressors, adequacy of social support and alcohol 
and substance misuse. There is greater detail on when ‘in house’ 
psychological support or intervention can be provided to patient, 
and when there should be referral to external appropriately trained 
psychological practitioners. There is emphasis that CPRPs should 
be aware of patients’ alcohol or substance misuse, and should 
offer onward referral to an appropriate resource if needed.1 The 
importance of identification and management (including onward 
referral, where required) of concerns or issues with sexual health 
or function is also highlighted.1
Although most of the new medical risk management compo-
nent contains the detail of the previous two components that 
have been combined, there is additional emphasis on erectile 
dysfunction (ED). Highlighting that ED can be multifactorial in 
CVD, with medication, vascular disease and psychogenic factors 
all potentially contributing, the document states that patients 
with ED should be considered for medication review and appro-
priate onward referral where indicated.1
Within long-term strategies (previously entitled ‘long-term 
management’), it is noted that, in addition to local community 
support groups, patients’ ongoing self-management approaches 
could include online tools/applications and self-monitoring 
resources.1 The component states that patients should be 
supported by partnership between primary and secondary care 
services to provide self-management strategies to help the tran-
sition from CPRP and continue to minimise the risk of long-
term CVD progression.1 Patients should be listed on GP Practice 
CHD/CVD registers.1
In this document,1 there is more detailed rationale for 
providing, and guidance on collecting, audit and evaluation 
data through NACR. Specifically, it states that, through the 
National Institute for Health and Care Excellence, the NHS 
and its services are required to offer CR to all eligible patients. 
With this, there is a duty to audit local performance and supply 
data to ensure national parity of service delivery.36 Furthermore, 
although CR uptake is improving, service quality is not equitable 
across the UK.36
This component outlines that audit can be done directly via 
NACR or through data upload from local provider software. 
Data entered directly or uploaded to NHS Digital (the organisa-
tion that hosts NACR data) should include both individual and 
service-level data based on assessment and including outcomes.1 
Where resources and service design permits, CPRPs are encour-
aged to provide 1-year follow-up data, which can be carried 
out within the NHS Digital-NACR software integrated with the 
patient journey, without duplication of work (figure 2).1
The 2017 standards and core components align with data 
requirements for the NCP_CR, and this component stresses that 
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the BACPR advocates that all programmes submit data and register 
for the NCP_CR so that patients, wherever they are in the UK, can 
be sure that the CPRP available to them meets agreed minimum 
standards.1
Funding
Monitor (a part of NHS Improvement) recommends the CR 
costing tool to enable CPRPs to generate the costs per staff profile 
required to meet the needs of its patient population.37 38 As this 
only considers staff costs over 16 one-hour sessions, CPRPs will 
need to add other capital and services costs and alter according 
to the number of sessions they run. The 2017 revised standards 
and core components place equivalent emphasis on lifestyle 
risk factor management, psychosocial health and medical risk 
factor management, while placing health behaviour change and 
education at the centre of this care. Therefore, costing devel-
oped within business cases and/or locally determine funding will 
need to reflect the expertise and time required for qualified and 
competent practitioners to apply an evidence-based approach 
across the six-stage pathway of CR (figure 1).
SummARy
In 2017, the BACPR published the third edition of its standards 
and core components for cardiovascular prevention and rehabili-
tation. Earlier editions of this publication were produced in 20072 
and 2012.3 4 The aim of the 2017 update was to further emphasise 
to commissioners, clinicians, politicians and the public the impor-
tance of robust, quality indicators of CR service delivery. While 
the 20123 4 edition of this document detailed seven standards and 
seven core components, the 2017 revision has six standards and 
six core components, with greater emphasis on quantifiable clinical 
and health outcomes, audit and certification.1
In working to build on the already extensive evidence base 
for CR, and expand the influence of prevention and rehabili-
tation services, innovative practice and close working between 
providers and commissioners is required. This should be done 
using the principles set out within this document as the prec-
edent on which all effective CPRPs are designed, underpinned 
by the framework of the CR six-stage pathway of care. Online 
educational modules are available to support implementation of 
the document. The CR costing tool should be used in financial 
planning of CPRPs, with quality assurance facilitated through 
local audit of performance, participation in the BHF NACR and 
ultimately attainment of national certification. Although devel-
oped for the UK, these standards and core components may 
apply equally to CPRPs in other countries.
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